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Methylation of 2H, 5-nitro- (1) and 2-ethyl, 5-nitro- (2) benzimidazoles separately with methyl iodide
in acetone in the presence of potassium carbonate yielded 2H, 5/6-nitro-(3A and 3B) and 2-ethyl, 5/6nitro- (4A and 4B) methylbenzimidazoles respectively. Methylation of 1 and 2 in dimethylformamide in
place of acetone yielded not only 3A, 3B and 4A, 4B respectively, but in addition 1,3-dimethyl-5-nitrobenzimidazol-2-one (5) was also obtained in each case. The structure of the synthesized compounds was
determined with the help of mass and 1 H NMR spectroscopic analysis.

Introduction
The benzimidazole ring structure is of particular interest especially within the realm of medicinal chemistry. Many of these compounds display a broad range of biological properties including antibacterial,
anthelmintic, antiinflammatory, anticancer, and antiviral activity. There is still interest in the synthesis of
benzimidazole derivatives for obtaining new biologically active compounds 1 . Benzimidazolone derivatives
are also medicinally important. They exhibit a wide variety of interesting biochemical and pharmacological
properties 1 . They antagonize neurotransmitters 2 , inhibit aldose reductase 3 , show antiulcer and antisecretory properties 4 , enhance pulmonary surfactant secretion 5 and modulate ion channels 6 .
During the current literature survey it was found that the unsymmetrical nitrobenzimidazoles a and
b shown in Fig. 1 were prepared as potential anti-viral agents 7 as analogs of acyclovir and ganciclovir.
These compounds were tested in the form of a mixture of regioisomers and no attempt was made to
separate the isomers. My research group has already succeeded 8 in preparing and separating several pairs
of unsymmetrical 2H- and 2-alkyl, 5/6-nitro, 5/6-chloro- and 5/6-methyl p-touene-sulphonylbenzimidazoles
respectively. “Cis” and “trans” configurations could be assigned to the synthesized isomers on the basis of
their respective 1 H NMR data, particularly NOE studies.
N
O2N
N
R
R = CH2OCH2CH2OH (a)
R = CH2OCH(CH2OH)2 (b)

Figure 1.
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In the light of the foregoing it seemed worthwhile to prepare more regioisomeric mixtures. Once ample
data on the separation, characterization and identification of the structure of regioisomers become available,
a systematic study of the dependence of biological activity on the regioisomeric structure might form an
important area of research for such compounds.
For this purpose 2H, 5-nitro- (1) and 2-ethyl, 5-nitro- (2) benzimidazoles were separately methylated
with methyl iodide in the presence of anhydrous potassium carbonate using acetone as solvent. The product
obtained from (1) after the usual work up could be separated into two compounds on fractional crystallization
from ethanol. They were found to be the expected regioisomers 2H, 5-nitro- (3A) and 2H, 6-nitro- (3B)
methylbenzmidazoles. Their structure was determined on the basis of their mass and 1 H NMR spectral
studies, which are to be discussed later. The product obtained from (2) on methylation under the same
conditions could be separated into two regioisomeric compounds 4A and 4B on similar work up. Their
structure was found to be 2-ethyl, 5-nitro- and 2-ethyl, 6-nitro-methylbenzimidazoles respectively on the
basis of their mass and 1 H NMR spectral studies, which will be described in the following section. However,
when the same two methylations were carried out using dimethylformamide as solvent in place of acetone,
an additional compound identified as 1,3-dimethyl-5-nitro-benzimidazol-2-one (5) was formed in both cases
in addition to the respective regioisomeric compounds described earlier Fig. 2. These results show that
some oxidation had occurred at 2-position in 5/6-nitro-subtituted benzimidazole ring after methylation in
the presence of dimethylformamide. The formation of 5 in these experiments may be due to the attack of
atmospheric oxygen. Moreover, the amount of 5 obtained during the methylation of 1 was much greater
than that formed in the methylation of 2. It seems that the presence of bulky alkyl group at 2-position in
the benzimidazole 2 hinders the attack of oxygen at that position.
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Further investigations, such as methylation of 1 and 2 in dimethylformamide under nitrogen atmosphere, will be carried out in order to study the role of atmospheric oxygen if any in the formation of 5.
Moreover, methylation of 2H- and 2-alkylbenzimdiazoles having no nitro-substituent in the benzene ring of
benzimidazoles will also be studied under similar conditions to see the effect of the nitro group on the results
of these reactions.

Spectral Studies
Mass spectral data
Mass spectral data of compounds 3, 4 and 5, which are in full agreement with their excepted structure, are
given in the Experimental section.

1

H NMR spectral studies

Compound 5: The structure of 5 has been confirmed with the help of 1 H NMR spectral measurements.
Proton magnetic resonance data of the compound are listed in the experimental. Five sets of peaks were
visible in the 1 H NMR spectrum of 5. The two singlets present at δ =3.40 and δ =3.45 were assigned to
two N-CH 3 protons. Protons H a and H b are ortho to nitro group, and hence they are more deshielded
than H c , which is meta to the NO 2 -group, so H a and H b were shifted downfield as compared to H c . The
lowest field doublet of doublet at δ =8.06 was assigned to H b , which had ortho coupling with H c (J bc =8.6
Hz) and meta coupling with H a (J ba =2.1 Hz). A doublet at δ =7.84 was due to H a , which showed meta
coupling with H b (J ab =2.1 Hz). The proton H c showed the highest field resonance of all aromatic protons
and appeared at δ =6.99.
Structure assignment of 3A and 3B “Trans” and “cis” assignment to pure regioisomers was made on
the basis of 1 H NMR spectral studies. Complete 1 H NMR data of regioisomers 3A and 3B are given in
the experimental.
It is the relative chemical shifts of the aromatic proton signals that distinguish 3A and 3B. By looking
at the “trans” and “cis” structure, one can understand that only H a in both regio-isomers has meta coupling.
In the “trans” regioisomer 3A, H a is ortho to NO 2 - and meta to N-CH 3 . In the cis regioisomer 3B H a is
ortho to both NO 2 - and N-CH 3 groups. Thus H a in 3A is more deshielded than H a in 3B. That is, H a in
3A should be shifted downfield as compared to H a in 3B. In 3A H a showed a doublet with meta coupling
(J ab =2.1) at δ =8.71, which is downfield as compared to the doublet with meta coupling (J ab =2.1) shown
by H a at δ =8.37 in 3B.
The other proton that plays a decisive role in “trans” and “cis” assignments to these structures is the
one attached to the 2-position of 3A and 3B, i.e., He. Of all the resonance forms that can be written for
3B, one has a positive charge at 2-position while no such resonance form is possible for 3A. Thus, H e in
3B should be shifted downfield as compared to the same proton H e in 3A. In 1 H NMR spectra of 3B, H e
showed a singlet at δ =8.11, which is downfield as compared to the singlet shown by H e at δ =8.05 in 3A.
In 3B, H b showed a doublet of doublet at δ =8.25 due to ortho and meta coupling with H c and H a protons
respectively. Similarly, H b in 3A showed a doublet of doublet at δ =8.22. A singlet at δ =3.92 in 3A and
at δ =3.95 in 3B was assigned to N-CH 3 protons.
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Structure assignment of 4A and 4B 1 H NMR data of compounds 4A and 4B are given in the Experimental section. The proton H a in both 4A and 4B has meta coupling with H b (J ab =2.2 Hz) and its
chemical shifts play a key role in trans and cis assignment to these structures. This proton in 4A exhibited
a doublet at δ =8.62 that was shifted downfield as compared to the doublet of H a at δ =8.28 in 4B. In 4A
and 4B the proton H b showed a doublet of doublet at δ =8.20 and δ =8.19 respectively. A quartet at δ =3.0
was assignable to -CH 2 and a triplet at δ =1.5 was assigned to CH 3 protons in the side chain. A singlet at
δ =3.81 was assigned to N-NH 3 in 4A and at δ =3.84 was assigned to N-CH 3 protons in 4B.
By looking at the 1 H NMR spectra of compounds 5, 3A, 3B, 4A and 4B it becomes clear that the
peak pattern of the aromatic protons is diagnostic for the two classes of closely related medicinal compounds,
i.e., substituted benzimidazolone and benzimidazoles. There are three sets of peaks: the two doublets, one
due to H a and the other due to H c , and the third doublet of doublet due to H b , which exhibits both ortho
and meta coupling. This doublet of doublet is in the middle of the two doublets in 3A, 3B, 4A and 4B
(benzimidazoles), whereas it appears at the lowest field in benzimidazolone.
To sum up, the “trans” regioisomers 3A and 4A are formed in higher yield and have higher melting
points as compared to the respective “cis” isomers.
NOE difference experiment NOE Difference was performed on 3B in order to establish the position
of the nitro group with respect to the methyl group present at position 1. For this purpose, 3B was
dissolved in deuterated methanol and its 1 H NMR spectrum was measured. The chemical shifts of 3B in
CD 3 OD are listed in the Experimental section. Irradiation of methyl protons (3.98 ppm) at N-1 resulted
in the enhancement of the H a (8.55 ppm) signal and not of the H c (7.76 ppm) doublet. This experiment
unequivocally determined the “cis” structure of 3B.
Hc
8.17 dd
(J1=8.7 Hz
J2=2.1 Hz)

7.76
(J=8.7 Hz)

Hb

N
He

O2N
Ha
8.55 d
(J=2.1 Hz)

8.39 s

N
d
CH3
3.98 s

It also interesting to note that the difference in the chemical shift of H a in 3A and 3B is exactly the
same as that in 4A and 4B, i.e., 0.34 ppm, the singlet for the “trans” (A) isomer appearing in the lower
field in both cases. Another interesting point is that the chemical shift difference of the three methyl protons
(N-CH 3 ) between 3A and 3B is 0.03 ppm, which is exactly the same as that between 4A and 4B. Here the
singlet for A appears at a higher field in both sets.
Experimental
All the solvents were distilled before use and dried as per requirement. The progress of the reactions
was monitored by thin-layer chromatography using pre-coated silica-gel 60HF 254 plates of 0.2 mm thickness
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(E. Merck).
Solvent systems used
a = CHCl 3 : MeOH (9:1)
b = CH 2 Cl 2 : MeOH (40:1)
c = EtOAc : Pet-ether (4:1)
Melting points were recorded on a Gallenkamp melting point apparatus (design No. 889339) and
are uncorrected. 1 H NMR spectra of the synthesized compounds were scanned in CDCl 3 solution unless
otherwise indicated, with a Bruker machine at the HEJ Research Institute of Chemistry, University of
Karachi. Chemical shifts are given in δ -scale (ppm). Mass spectra (low resolution) of the synthesized
compounds were recorded at MAT 120 at the HEJ Research Institute of Chemistry, University of Karachi.
2H, 5-Nitrobenzimidazole (1) was prepared by the known procedure, i.e., refluxing 1,2-diamino-4nitrobenzene with formic acid in 4N HCl and the usual work up. 2-Ethyl, 5-nitro-benzimidazole (2) was
prepared with the same procedure using propionic acid in place of formic acid.
Preparation of 1-methyl-5/6-nitro-benzimidazoles (3A and 3B)
Compound 1 (4g; 0.024M), methyl iodide (1.51ml; 0.02M) and anhydrous potassium carbonate (3.3g;
0.023M) were refluxed in dry acetone (200ml) for four hours. Removal of solvent under reduced pressure
yielded the yellow solid (3.0g), which showed a single spot on thin-layer chromatography plate (R f =0.72 a ,
0.45 b , 0.20 c ).
Separation of 3a and 3b
Mixture of 3A and 3B (3.0g) was dissolved in a minimum amount of ethanol and kept overnight.
The next day colourless crystals were formed. After filtration the mother liquor was concentrated and kept
overnight. The crystals so obtained were filtered. The process was repeated. The three crops of crystals
showing the same melting point were combined to give 3B (2.1g). The solvent was removed from the mother
liquor in vacuo and the dry residue was recrystallized from acetone, yielding brown crystals of 3B (0.6g).
Compound 3A: Yield 2.1g (64%); m.p. = 200 ◦ (ethanol), R f =0.72 a , 0.45 b , 0.20 c . 1 H-NMR: δ =8.71 (d,
H a , 1H, J ab =2.1 Hz); δ =8.25 (dd, H b , 1H, J bc =8.25, J ba =2.1); δ =8.05 (s, H e , 1H); δ =7.45 (d, H a ,
1H, J cb =8.9 Hz); δ =3.92 (s, H d , 3H). MS: 177(100) [M +
· ]; 147(11.43), 131(44), 120(6.1), 104(35), 91(3.3),
75(5.3).
Compound 3B: Yield 0.6g (8%); m.p. = 133 ◦ (ethanol), R f =0.72 a , 0.45 b , 0.20 c . 1 H-NMR: δ =8.37, 8.55 ?
(d, H a , 1H, J ab =2.1 Hz); δ =8.22, 8.17 ? (dd, H b , 1H, J cb =8.9, J ba =2.2 Hz); δ =8.11, 8.39 ? (s, H e , 1H);
δ =7.85, 7.76 ? (d, H c , 1H, J cb =8.7 Hz); δ =3.95, 3.98 ? (s, H d , 3H). MS: same as for 3A.
?

Measured in CD 3 OD

Preparation of 2-ethyl-1-methyl-5/6-nitro-benzimidazoles (4A and 4B): Compound 2 (4g, 0.02M),
methyl iodide (1.29ml, 0.02M) and anhydrous potassium carbonate (2.87g, 0.02M) were refluxed in dry acetone (250ml) for six hours. After the removal of the solvent, the yellow solid of the regioisomeric mixture
4A and 4B was obtained, which gave a single spot in thin-layer chromatograph (R f =0.87 a , 0.41 b , 0.33 e ).
Separation of 4A and 4B:
Separation of 4A and 4B was achieved through fractional crystallization as described for 3A and 3B.
Compound 4A: Yield 1.9g (69%); m.p. = 182 ◦ (ethanol), R f =0.87 a , 0.41 b , 0.33 e . 1 H-NMR: δ =8.62 (d,
1H, J ab =2.1 Hz); δ =8.20 (dd, H b , 1H, J bc =8.9 Hz, J ba =2.2 Hz); δ =7.34 (d, H c , 1H J cb =8.9 Hz); δ =3.81
(s, H d , 3H); δ =2.99, (q, H e , 2H, J e,b =7.5 Hz); δ =1.50 (t, H f , 3H, J e,f =7.5 Hz). MS: 205(100) [M +
· ],
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204(64), 190(4.7), 177(2.3), 176(5.05), 175(1.89), 147(2.42), 131(5.2), 91(6.04), 75(4.5).
Compound 4B: Yield =0.5g (18%); m.p. = 133 ◦ (acetone); R f =0.87 a , 0.41 b , 0.33 e . 1 H-NMR: δ =8.28
(d, H a ,1H, J ab =2.1 Hz); δ =8.19 (dd, H b , 1H, J bc =8.9 Hz, J ba =2.2 Hz); δ =7.17 (d, H c , 1H J cb =8.9 Hz);
δ =3.84 (s, H d , 3H); δ =3.0, (q, H e , 2H, J e,f =7.5 Hz); δ =1.5 (t, H f , 3H, J e,f =7.5 Hz). MS: same as for
4A.
Preparation of 1,3-dimethyl-2H-5-nitrobenzimidazol-2-one (5) and 1-methyl-2H-5/6
-nitro-benzimidazoles (3A and 3B) and separation of the two classes of compounds
Compound 1 (20g, 0.12M), methyl iodide (12.35ml, 0.24M) and anhydrous potassium carbonate (33g, 0.24M)
were dissolved in dry N,N-dimethylformamide (250ml) and refluxed for 36 hours. After the completion of the
reaction, the solvent was removed in vacuo. The residue was dissolved in water. The mixture was extracted
in chloroform and chloroform layer washed thoroughly with water. The organic layer was then dried over
anhydrous sodium sulphate, and the solvent was removed under vacuum, leaving, a crude brown solid. The
mixture showed two spots on the thin layer chromatogram; 3(R f =0.72 a , 0.32 b ) and 5(R f =0.93 a , 0.84 b ).
The crude mixture was recrystallized from methanol, yielding light yellow crystals of compound 5. The thinlayer chromatogram of the mother liquor showed two spots corresponding to compounds 3 and 5 in almost
equal amounts. The solvent was removed in vacuo and the residue was subjected to column chromatography
using a gradient of n-hexane and ethylacetate. Fractions obtained with n-hexane : ethylacetate (7:3) gave
pure 5, and those with n-hexane : ethylacetate (1:1) contained a mixture of 3A and 3B.
Compound 5: Yield =15g (59%); m.p. = 202 ◦ (methanol); R f =0.936 a 0.84 b . 1 H-NMR: δ =8.06 (dd,
H b ,1H, J bc =6.32 Hz); δ =7.84 (d, H a , J ab =2.5 Hz; δ =6.99 (d, H c , 1H J cb =8.61 Hz); δ =3.40 (s, H d ,
3H); δ =3.45, (s, H e , 3H). MS: 207(100) same as for 4A [M +
· ], 177(13.5), 161(51.5), 147(11.26), 133(7.46),
91(6.08), 75(3.2).
Compound 3 (A and B: Yield=1.5g(7%); m.p. =150 ◦ , R f =0.72 a , 0.45 b . MS: 177(100) [M +
· ], 147(18.44),
111(48.5), 104(24.06), 120(8.3), 91(2.1), 75(6.5).
Preparation of 5 and 2-ethyl-5-methyl-5/6-nitrobenzimidazoles (4A and 4B) and
separation of the two classes of compounds
Compound 2 (3g, 0.15M), methyl iodide (1.94ml, 0.0314M) and anhydrous potassium carbonate (4.3g,
0.0314M) were dissolved in dry dimethylformamide (250ml) and refluxed for 36 hours. After the completion
of the reaction, the solvent was removed in vacuo. The residue was dissolved in water. The mixture
was extracted with chloroform, and the chloroform layer was washed thoroughly with water. The organic
layer was then dried over anhydrous sodium sulphate and filtered. Removal of the solvent under reduced
pressure gave a brown solid. A thin-layer chromatogram of this mixture showed two spots, one of compound
4(R f =0.87 a , 0.41 b ) and the other of compound 5(R f =0.93 a , 0.84 b ). The separation of 4 and 5 was
achieved by subjecting it to column chromatography using a gradient of dichloromethane and methanol.
Fractions obtained with dichloromethane: methanol (9:1) gave pure 5 and those with methylene chloride :
methanol (2:1) gave a mixture of 4A and 4B.
Compound 5: Yield=500mg(15%); m.p. =202 ◦ (methanol), R f , 1 H NMR and MS: as already described.
Compound 4 (A and B): Yield=1.5g(47%), m.p. =140 ◦ , R f =0.87 a , 0.41 b . MS: 205(100) [M +
· ], 204(64.4),
190(4.8), 176(1.92), 170(4.03), 159(29), 147(3.15), 131(4.56), 104(11.7), 91(3.8), 75(4.8).
Compounds 1 and 2 were separately methylated in dry acetone in the presence of anhyd, potassium
carbonate using double molar ratios of methyl iodide. Thin-layer chromatography of the product obtained
after the usual work-up showed the absence of 5 in both experiments.
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